In this study, we report that SFN downregulated PD-1 expression in CAR-T cells by inhibiting the PI3K/AKT pathway, while SFN promoted PD-L1 degradation in tumor cells by activating the ubiquitination-mediated proteolysis pathway. This evidence concerns the gene PDCD1 and neoplasm.